Novel approach for determination of correlation between in vivo and in vitro dissolution using the optimization technique

Chemical and Pharmaceutical Bulletin

Volumn 44, Issue 8, 1996, Pages 1550-1555

  Ishii, Kuniaki ^a   Saitou, Yoko ^a   Yamada, Ryota ^a   Itai, Shigeru ^a   Nemoto, Masami ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

in vitro dissolution; in vivo dissolution; in vivo in vitro correlation; optimization technique

Indexed keywords

IBUPROFEN;

ARTICLE; DRUG ABSORPTION; DRUG FORMULATION; DRUG SOLUBILITY; MATHEMATICAL ANALYSIS; PH; REGRESSION ANALYSIS;

EID: 0029741052     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.44.1550     Document Type: Article

References (18)

1. A part of this work was presented at the 115th Annual Meeting of the Pharmaceutical Society of Japan, Sendai, March 1995, Abstract of Papers, p. 74.
2. Langenbucher F., Mysicka J., Br. J. Clin. Pharm., 19, 151S- 162S (1985); Kottke M. K., Rhodes C. T., Drug Dev. Ind. Pharm., 17, 1157-1176 (1991); Stavochansky S., Doluisio J. T., Martin A., Martin C., Cabana B., Dighe S., Loper A., J. Pharm. Sci., 69, 1307-1310 (1980).
3. Langenbucher F., Mysicka J., Br. J. Clin. Pharm., 19, 151S- 162S (1985); Kottke M. K., Rhodes C. T., Drug Dev. Ind. Pharm., 17, 1157-1176 (1991); Stavochansky S., Doluisio J. T., Martin A., Martin C., Cabana B., Dighe S., Loper A., J. Pharm. Sci., 69, 1307-1310 (1980).
4. Langenbucher F., Mysicka J., Br. J. Clin. Pharm., 19, 151S- 162S (1985); Kottke M. K., Rhodes C. T., Drug Dev. Ind. Pharm., 17, 1157-1176 (1991); Stavochansky S., Doluisio J. T., Martin A., Martin C., Cabana B., Dighe S., Loper A., J. Pharm. Sci., 69, 1307-1310 (1980).
5. Möller H., Langenbucher F., Pharm. Ind., 44, 1065-1071 (1982); Bradbrook I. D., John V. A., Morrison P. J., Rogers H. J., Spector R. G., Br. J. Clin. Pharmac., 19, 163S-169S (1985).
6. Möller H., Langenbucher F., Pharm. Ind., 44, 1065-1071 (1982); Bradbrook I. D., John V. A., Morrison P. J., Rogers H. J., Spector R. G., Br. J. Clin. Pharmac., 19, 163S-169S (1985).
7. Oribe A., Takahashi M., Shirakura O., Ishimaru S., Goto S., Takayama K., Nagai T., Abstracts of Papers, The 112th Annual Meeting of the Pharmaceutical Society of Japan, Fukuoka, March 1992, p. 27.
8. Takayama K., Nambu N., Nagai T., Chem. Pharm. Bull., 31, 4496-4507 (1983); Takayama K., Nagai T., ibid., 37, 160-167 (1989); idem, Int. J. Pharm., 74, 115-126 (1991).
9. Takayama K., Nambu N., Nagai T., Chem. Pharm. Bull., 31, 4496-4507 (1983); Takayama K., Nagai T., ibid., 37, 160-167 (1989); idem, Int. J. Pharm., 74, 115-126 (1991).
10. Takayama K., Nambu N., Nagai T., Chem. Pharm. Bull., 31, 4496-4507 (1983); Takayama K., Nagai T., ibid., 37, 160-167 (1989); idem, Int. J. Pharm., 74, 115-126 (1991).
11. Iga K., Ogawa Y., Yashiki T., Shimamoto T., J. Pharmacokinet. Biopharm., 14, 213-225 (1986); Yamaoka K., Tanigawara Y., "A Primer on Pharmacokinetics Using a Microcomputer," Nankodo, Tokyo, 1983.
12. Iga K., Ogawa Y., Yashiki T., Shimamoto T., J. Pharmacokinet. Biopharm., 14, 213-225 (1986); Yamaoka K., Tanigawara Y., "A Primer on Pharmacokinetics Using a Microcomputer," Nankodo, Tokyo, 1983.
13. Wagner J. G., Nelson E., J. Pharm. Sci., 53, 1392-1403 (1964).
14. Haga T., Takeuchi H., Okuno T., Quality J.S.Q.C., 6, 35-40 (1976).
15. Millar F. C., Corrigan O. I., Int. J. Pharmaceut., 92, 97-104 (1993).
16. Aoyagi N., Ogata H., Kaniwa N., Ejima A., Int. J. Clin. Pharmacol. Ther. Toxicol., 23, 529-534 (1985).
17. Katori N., Aoyagi N., Terao T., Pharm. Res., 12, 237-243 (1995).
18. Aoyagi N., Ogata H., Kaniwa N., Ejima A., Nakata H., Tsutsumi J., Fujita T., Amada I., Int. J. Clin. Pharmacol. Ther. Toxicol., 23, 578-584 (1985).